StockData
Balchem Corp logo

Balchem Corp (BCPC) stock

BCPCNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 19/3014% above fair value
$168.73−0.90 (-0.53%)

Close on Nov 18, 2026Market cap $5.36BP/E 31.8Yield 0.57%

Balchem revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Balchem's revenue for the twelve months ending Sep 30, 2026 was $1.11B, up 9.4% year over year. For fiscal 2025 it was $1.04B, up 8.8% from the year before. Over ten years it grew 6.5% a year on average. The highest annual figure on record is $1.04B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.04B+8.8%
FY2024Dec 31, 2024$953.68M+3.4%
FY2023Dec 31, 2023$922.44M-2.1%
FY2022Dec 31, 2022$942.36M+17.9%
FY2021Dec 31, 2021$799.02M+13.6%
FY2020Dec 31, 2020$703.64M+9.3%
FY2019Dec 31, 2019$643.71M+0.0%
FY2018Dec 31, 2018$643.68M+8.2%
FY2017Dec 31, 2017$594.79M+7.5%
FY2016Dec 31, 2016$553.20M+0.1%
FY2015Dec 31, 2015$552.49M+2.1%
FY2014Dec 31, 2014$541.38M+60.6%
FY2013Dec 31, 2013$337.17M+8.6%
FY2012Dec 31, 2012$310.39M+6.3%
FY2011Dec 31, 2011$291.87M+14.4%
FY2010Dec 31, 2010$255.07M+16.2%
FY2009Dec 31, 2009$219.44M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$290.66M+8.6%
Q2 FY2026Jun 30, 2026$284.00M+11.2%
Q1 FY2026Mar 31, 2026$270.71M+8.1%
Q4 FY2025Dec 31, 2025$263.62M+9.8%
Q3 FY2025Sep 30, 2025$267.56M+11.5%
Q2 FY2025Jun 30, 2025$255.47M+9.1%
Q1 FY2025Mar 31, 2025$250.52M+4.5%
Q4 FY2024Dec 31, 2024$240.00M+4.9%
Q3 FY2024Sep 30, 2024$239.94M+4.3%
Q2 FY2024Jun 30, 2024$234.08M+1.2%
Q1 FY2024Mar 31, 2024$239.66M+3.1%
Q4 FY2023Dec 31, 2023$228.70M-1.6%
Q3 FY2023Sep 30, 2023$229.95M-5.9%
Q2 FY2023Jun 30, 2023$231.25M-2.3%
Q1 FY2023Mar 31, 2023$232.54M+1.6%
Q4 FY2022Dec 31, 2022$232.53M+9.1%
Q3 FY2022Sep 30, 2022$244.27M+23.4%
Q2 FY2022Jun 30, 2022$236.69M+17.0%
Q1 FY2022Mar 31, 2022$228.87M+23.3%
Q4 FY2021Dec 31, 2021$213.13M+17.9%
Q3 FY2021Sep 30, 2021$197.87M+13.0%
Q2 FY2021Jun 30, 2021$202.37M+16.7%
Q1 FY2021Mar 31, 2021$185.66M+6.4%
Q4 FY2020Dec 31, 2020$180.71M+8.5%
Q3 FY2020Sep 30, 2020$175.14M+10.4%
Q2 FY2020Jun 30, 2020$173.36M+7.3%
Q1 FY2020Mar 31, 2020$174.44M+11.1%
Q4 FY2019Dec 31, 2019$166.53M+1.8%
Q3 FY2019Sep 30, 2019$158.60M+2.3%
Q2 FY2019Jun 30, 2019$161.55M-1.3%
Q1 FY2019Mar 31, 2019$157.03M-2.7%
Q4 FY2018Dec 31, 2018$163.54M+2.7%
Q3 FY2018Sep 30, 2018$155.04M+2.9%
Q2 FY2018Jun 30, 2018$163.69M+11.3%
Q1 FY2018Mar 31, 2018$161.41M+17.2%
Q4 FY2017Dec 31, 2017$159.26M+13.1%
Q3 FY2017Sep 30, 2017$150.72M–
Q2 FY2017Jun 30, 2017$147.08M–
Q1 FY2017Mar 31, 2017$137.73M–
Q4 FY2016Dec 31, 2016$140.76M–

More Balchem figures

See a number that looks wrong?